Interactions between carboplatin, cisplatin and ionising radiation in a human ovarian cancer cell line;Interactions entre le carboplatine, le cisplatine et les rayonnements ionisants dans une lignee cellulaire humaine de cancer ovarien

Cancer/Radiotherapie

Volumn 3, Issue 1, 1999, Pages 30-38

  Scalliet, P ^a   De Footer, C ^b   Hellemans, P W J ^c   De Bruijn, E A ^a   Van Oosterom, A T ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UZ Gasthuisterg   (Belgium)

Author keywords

Carboplatin; Chemoradiotherapy; Cisplatin; Ionising radiation; Ovarian cancer; Radiobiology; Radiosensibilisation

Indexed keywords

CARBOPLATIN; CISPLATIN;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL SURVIVAL; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIZING RADIATION; OVARY CANCER; PRIORITY JOURNAL; RADIATION DOSE;

EID: 0032756277     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(99)80032-8     Document Type: Article

References (35)

1. Alvare? MV, Cobreros G, Heras A, Lopez Zumel ML. Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer. Br J Cancer 1978 : 37 : 68-72
2. Barot HA, Laverick M, Nias AHW. The radiomimetic properties of a platinum drug. Br J Radiol 1985 ; 8 : 51-62
3. Begg AC, Van der Kolk H, Dewit L, Bartelink H. The interaction of cisplatinum and radiation on RIF-1 tumour cells in vitro. Int J Radial Biol 1986; 5 : 871-84
4. Begg AG, Van der Kolk PJ, Edmondl J, Bartelink H. Radiosensitization in vitro by cis-diammine (1,1-cyclobutanedicarboxylato) platinum (II) (carboplatin, JM8) and athylenediammine-malonatoplatinum (II) (JM40). Rad Oncol 1987 ; 9 : 157-65
5. Biaglow JE, Varnes ME. The role of thiols in cellular response to radiation and drugs. Radial Rts 1983 ; 95 : 437-55
6. Carde P. Lavai F. Effect of cis-diamminedic:hloroplatinum (II) and X rays on mammalian cell survival, [nt J Radial Oncol Biol Phys 1981 ; 7: 929-33
7. Chadwick KH, Leenhouts HP, Szumiel I, Nias AHW. An analysis of the interaction of a platinum complex and radiation with CHO cells using the molecular theory of cell survival. Int J Radial Oncol Biol 1985;3(l:511-24
8. Chibber L, Stratford IJ, O'Niel P, Sheldon PW, Ahmed I, Lee B. The interactions between radiation and comlexes of cis-Pt (II) and Rh (II): studies a; the molecular and cellular level. Int J Radial Oncol Biol 1985 ;4&: 513-24
9. Coughlin CT, Richmond RC. Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emerge for carboplatin. Sem Oncol 1989 ; 16 : 31-43
10. DeaconJ, PeckhamMJ, Steel GG. The radioresponsiveness of human tunours and the initial slope of the celle survival curve. Radiother Oncol 1984:2:317-23
11. De Footer CHMJ, Scalliet PS. Elst HJ, Huybrechts JJ, Gheuens EEO, van Oosterom AT et al. Resistance patterns between cis-diamminedichloroplatinum (II) and ionizing radiation. Cancer Res 1991 : 51 ; 4523-7
12. Dewit L. Combined treatment of radiation and cis-diamminedichloroplatinum (II). A review of experimental and clinical data. Int J Radiât Oncol Biol Phys 1987 ; 13 : 403-26
13. Douple EB, Richmond RC. Platinum complexes as radiosensitizers of hypoxic mammalian cells. Br J Cancer 1978 ; 37 : 98-102
14. Fertil, B, Malaise EP. Inherent radiosensitivity as a basic concept for human tumour radiotherapy. Int J Radiât Oncol Biol Phys 1981 ; 7 : 621-9
15. Douple EB, O'hara EB, Jones EL. Paraplatin enhancement of radiation therapy in a murine tumor (MTG-B). In: Lapis K, Eckhart S, eds. Anticancer Drut Research. Akademiai Kiado: Budapest; 1987. p 71-9
16. Flentjes M, Able M, Haner U, Trinh S, Wannenmacher M. Additive effects of cisplaitn and radiation in human tumor cells under toxic conditions. Rad Oncol 1992 ; 24 : 60-3
17. Guchelaar HJ, de Vries EG, Meijer C, Esselink MT, Vellenga E, Uges DR et al. Effect of ultrafiltrable platinum concentration on cisplatin and caboplatin cytotoxicity in human tumor and bone marrow cells in vitro. Pharmaceut Res 1994 : 11 : 1265-9
18. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the oesophagus. New Eng J Med 1992 ; 326 : 1593-8
19. Kaufman DS, Shipley WU, Griffin PP, Heney NM, Althausen AF, Efird JT. Selective bladder preservation by combination treatment of invasive bladder cancer. New Eng J Med 1993 ; 329 : 1377-82
20. Knox RJ, Friedlos F, Lydall DA, Roberts JJ. Mechanism of cytotoxicity of anticancer drug: that cis-diamminedichloroplatinum (II) and cis-diammine (1,1 cyclobutanedicarboxylato) platinum (II) differ only in the kinetics of their interaction with DNA. Cancer Res 1986 ; 46: 1972-9
21. Kuppen PJK, Schuitemaker H, Van'1 Veer LJ, de Bruijn EA, van Oosterom, AT, Schrier PI. Cis-diamminedichloroplatinum (H)-resistant sublines derived from two human ovarian tumor cell lines. Cancer Res 1988 ; 48 : 3355-9
22. Lambin P, Scalliet P, Coster B, M'Vondo JC, Vynckier S, Gueulette J ei al. Influence of cisplatinum on intestinal tolerance of photon and neutron irradiation in mice. Radiother Oncol 1993 ; 26 : 73-5
23. Los G, Verdegaal E, Noterborn HPJM, Ruevekamp M, de Graeff A, Meesters EW et al. Cellular pharmacokinetics of carboplatin and cisplatin in relation to their cytotoxic action. Biochem Pharmacol 1991; 42: 357-63
24. Murthy AK, Rossof AM, Anderson KM, Hendrickson FR. Cytotoxicity and influence on radiation dose response curve of cis-diamrninedichloroplatinum (II) (cis-DDP). Int J Radiât Oncol Biol 1979 ; 5 : 1411-524
25. O'Hara JA, Douple EB, Richmond RC. Enhancement of radiationinduced cell kill by platinum complexes (carboplatin and iproplatin) in V79 cells. Int J Radiât Oncol Biol Phys 1986 ; 12 : 1419-22
26. Richmond RC, Powers EL. Radiation sensitization of Bacterial spores, by cis- dichlorodiammineplatinum (II). Radial Res 1976 ; 68 : 251-7
27. Richmond RC, Zimbrick JD, Hykes DL. Radiation-induced DNA damage and lethality in E Coli as modified by the antitumor agent ds-dichlorodiammineplatinum (II). Radiât Res 1977 ; 71 : 447-60
28. Richmond RC, Simic MG. Effect of radiation on cis-dichlorodiammineplatinum (II) and DNA in aqueous solution. Br J Cancer 1978 ; 37 : Suppl III : 20-3
29. Richmond RC, Kelman AD. Effect of aqueous free radicals and cisdichlorodiammineplatinum (11) on radiation-induced base release from DNA. Radiât Res 1981 ; 88 : 476-88
30. Richmond RC, Khokhar AR, Teicher BA. Toxic variability and radiation sensitization by Ft (II) analogs in Styphimurium cells. Radiât Res 1984 ; 99 : 609-26
31. Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P et al. Effects of concomitant ciplatin and radiotherapy on inoperable non-small-cell-lung cancer. New Eng J Med 1992 ; 326 : 524-30
32. Sinclair WK. Cyclic X-ray responses in mammalian cells in vitro. Radial Res 1968 ; 33 : 620-43
33. Towle LR, Hall EJ, Capuono L. Studies with cis-platinumdiamminedichloride at the cellular level. Radiât Res 1980 ; 83 : 37-8
34. Wodinsky I, Swiniarski J. KenslerCJ. Combination radiotherapy and chemotherapy for p388 Ivmphocytic leukemia in vivo. Cancer Treat Rep 1974 ; 4 : 73-80
35. Zak M, Drobnik J. Effect of cis-dichlorodiamrnineplatinum (II) on the post-irradiation lethality in mice after irradiations with X-rays. Strahlentherapie 1971 ; 142 : 112-5